| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |